Cancel anytime
Cibus Global LLC (CBUS)CBUS
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2024: CBUS (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Profit: -61.18% | Upturn Advisory Performance 1 | Avg. Invested days: 41 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 09/18/2024 |
Type: Stock | Today’s Advisory: PASS |
Profit: -61.18% | Avg. Invested days: 41 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 09/18/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 132.58M USD |
Price to earnings Ratio - | 1Y Target Price 19.75 |
Dividends yield (FY) - | Basic EPS (TTM) -3.6 |
Volume (30-day avg) 215577 | Beta 1.84 |
52 Weeks Range 3.58 - 23.18 | Updated Date 09/18/2024 |
Company Size Small-Cap Stock | Market Capitalization 132.58M USD | Price to earnings Ratio - | 1Y Target Price 19.75 |
Dividends yield (FY) - | Basic EPS (TTM) -3.6 | Volume (30-day avg) 215577 | Beta 1.84 |
52 Weeks Range 3.58 - 23.18 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -2563.48% |
Management Effectiveness
Return on Assets (TTM) -6.78% | Return on Equity (TTM) -79.11% |
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 126563924 | Price to Sales(TTM) 44.77 |
Enterprise Value to Revenue 42.74 | Enterprise Value to EBITDA -1.15 |
Shares Outstanding 23088500 | Shares Floating 16631829 |
Percent Insiders 26.4 | Percent Institutions 35.95 |
Trailing PE - | Forward PE - | Enterprise Value 126563924 | Price to Sales(TTM) 44.77 |
Enterprise Value to Revenue 42.74 | Enterprise Value to EBITDA -1.15 | Shares Outstanding 23088500 | Shares Floating 16631829 |
Percent Insiders 26.4 | Percent Institutions 35.95 |
Analyst Ratings
Rating 4.25 | Target Price 25.33 | Buy 1 |
Strong Buy 2 | Hold 1 | Sell - |
Strong Sell - |
Rating 4.25 | Target Price 25.33 | Buy 1 | Strong Buy 2 |
Hold 1 | Sell - | Strong Sell - |
AI Summarization
Cibus Global LLC: A Comprehensive Overview
Company Profile:
Detailed history and background of Cibus Global LLC:
Cibus Global LLC is a plant breeding and agricultural biotechnology company headquartered in San Diego, California. Founded in 2007, the company focuses on developing and commercializing non-transgenic, non-GMO seeds and novel traits for major agricultural crops like soybean, canola, and corn.
Cibus Global has a unique approach to plant breeding. Instead of using genetic engineering, the company utilizes new gene editing technologies like Cas9, TALENs, and CRISPR to create non-GMO plants with improved traits. These traits can include higher yields, pest resistance, better nutrient composition, and increased disease resistance.
Description of the company's core business areas:
Cibus Global operates in two core business areas:
- Seed development and breeding: The company develops high-performing, non-GMO seeds for major crops using gene editing and advanced breeding techniques. They focus on improving key traits like yield, nutrient composition, stress resistance, and disease resistance.
- Licensing of gene editing technology: Cibus Global licenses its proprietary gene editing technologies like the Cibus Gene Editing Toolkit (CGET) to other plant breeding companies, enabling them to develop non-GMO crops with improved traits.
Overview of the company's leadership team and corporate structure:
The Cibus Global leadership team includes:
- Peter Beetham, Ph.D. (President & CEO): Dr. Beetham has extensive experience in the agricultural biotechnology industry, with a background in genomics, breeding, and plant engineering.
- David R. Voss (Chief Commercial Officer): Voss brings decades of experience in commercializing agricultural technologies and products.
- David Mezzapelle (Chief Operating Officer): Mezzapelle has a strong track record in operations management and supply chain optimization within the agriculture industry.
- Robert L. Reiter (Executive Vice President & Chief Financial Officer): Reiter possesses significant experience in corporate finance and strategic planning within biotechnology and technology companies.
- David J. Chitwood, Ph.D. (Executive Vice President, R&D): Dr. Chitwood leads Cibus Global's research and development efforts, bringing expertise in crop breeding and genetics.
- David F. Kvamme (Chairman of the Board): Kvamme has extensive experience in leading and shaping technology-driven companies.
Cibus Global also has a strong advisory board with significant expertise in plant breeding, biotechnology, agronomy, and business strategy.
Top Products and Market Share:
Identification and description of Cibus Global LLC's top products and offerings:
Cibus Global's top products are its non-GMO trait lines for major crops:
- High oleic soybean trait: This trait increases the oleic acid content in soybean oil, resulting in a healthier oil with improved stability and oxidation resistance.
- Low linolenic soybean trait: This trait reduces the linolenic acid content in soybean oil, enhancing its shelf life and performance in food applications.
- Cibus Herculex RC (herbicide resistance trait): This trait provides resistance to the popular herbicide dicamba in soybean crops.
- Corn with increased digestibility trait: This trait improves the digestibility of starch in corn, benefitting livestock and feed production.
Analysis of the market share of these products in the global and US markets:
Cibus Global is a relatively young company that is still expanding its market presence. However, its non-GMO traits have gained substantial market share in specific segments:
- Soybean: Cibus Global holds a market share of around 25% for non-GMO, high oleic soybeans in the US.
- Canola: The company is a leader in the non-GMO, low linolenic canola segment, with a significant market share in North America.
Comparison of product performance and market reception against competitors:
Cibus Global's non-GMO products are positioned differently than competing GMO products in the market. They offer an alternative for consumers and food companies seeking non-GMO solutions while providing improved performance attributes like higher yields, better oil quality, and increased digestibility.
Total Addressable Market:
Cibus Global operates in a substantial and growing market. The global market for non-GMO food is estimated to reach over $3 trillion by 2027, fueled by the increasing consumer demand for healthy and sustainable food options. The market for gene-edited crops is also
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cibus Global LLC
Exchange | NASDAQ | Headquaters | San Diego, CA, United States |
IPO Launch date | 2023-06-01 | Co-Founder, CEO & Chairman | Mr. Rory Balfour Riggs M.B.A. |
Sector | Healthcare | Website | https://www.cibus.com |
Industry | Biotechnology | Full time employees | 183 |
Headquaters | San Diego, CA, United States | ||
Co-Founder, CEO & Chairman | Mr. Rory Balfour Riggs M.B.A. | ||
Website | https://www.cibus.com | ||
Website | https://www.cibus.com | ||
Full time employees | 183 |
Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.